Registration number: 11721747

Oxford Healthtech Ltd.

Contents

Balance Sheet	1
Notes to the Unaudited Financial Statements	2 to 6

Oxford Healthtech Ltd.

(Registration number: 11721747)
Balance Sheet as at 31 December 2024

	Note	2024 £	2023 £
Fixed assets
Intangible assets	4	70,623	-
Tangible assets	5	3,307	2,458
		73,930	2,458
Current assets
Debtors	6	57,869	134,304
Cash at bank and in hand		69,073	74,717
		126,942	209,021
Creditors: Amounts falling due within one year	7	(452,060)	(303,627)
Net current liabilities		(325,118)	(94,606)
Net liabilities		(251,188)	(92,148)
Capital and reserves
Called up share capital		150	150
Share premium reserve		59,950	59,950
Retained earnings		(311,288)	(152,248)
Shareholders' deficit		(251,188)	(92,148)

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 25 September 2025 and signed on its behalf by:
 

......................................... S E Huq Director

Oxford Healthtech Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
2 Old Bath Road
Newbury
Berkshire
RG14 1QL
England

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The directors believe the going concern basis to be appropriate by virtue of the continued support of the directors and shareholders and through grant funding which will help to support the company in relation to its ongoing expenditure.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for professional, scientific and technical activies. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Tax

The tax expense for the period comprises current tax payable.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Plant and equipment	20% reducing balance

Oxford Healthtech Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Intangible assets

Separately acquired trademarks and licences are shown at historical cost.

Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date.

Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class	Amortisation method and rate
Patents	5% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

Oxford Healthtech Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

4	Intangible assets

	Trademarks, patents and licenses  £	Total £
Cost or valuation
Additions acquired separately	72,750	72,750
At 31 December 2024	72,750	72,750
Amortisation
Amortisation charge	2,127	2,127
At 31 December 2024	2,127	2,127
Carrying amount
At 31 December 2024	70,623	70,623

Oxford Healthtech Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

5	Tangible assets

	Plant and machinery £	Total £
Cost or valuation
At 1 January 2024	4,924	4,924
Additions	1,415	1,415
At 31 December 2024	6,339	6,339
Depreciation
At 1 January 2024	2,466	2,466
Charge for the year	566	566
At 31 December 2024	3,032	3,032
Carrying amount
At 31 December 2024	3,307	3,307
At 31 December 2023	2,458	2,458

6

Debtors

	2024 £	2023 £
Prepayments	24,191	65,642
Other debtors	33,678	68,662
	57,869	134,304

7

Creditors

Creditors: amounts falling due within one year

	2024 £	2023 £
Due within one year
Trade creditors	2,730	283
Taxation and social security	1,593	1,166
Other creditors	447,737	302,178
	452,060	303,627

Oxford Healthtech Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024